At least $400 million was spent in first-half 1996 in trying to influence the US federal government, reports an Associated Press analysis of the first disclosures under a new lobbying act.
While the figure is the most comprehensive yet of the amount special interests spend, experts feel it is conservative as it ignores money spent on grass-roots lobbying and because the first half of 1996 was a quieter than usual period for lobbyists.
Some of the largest spenders were health care-related, including: American Medical Association, $8.5 million; Chemical Manufacturers Association, $4.5 million; Pfizer, $4.2 million; Health Insurance Association of America, $3.3 million; Blue Cross/Blue Shield, $2.5 million; Glaxo Wellcome, $2.1 million; Merck & Co, $1.9 million; American Hospital Association, $1.8 million; American Insurance Association, $1.7 million; Aetna, $1.3 million; and Prudential, $1.3 million.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze